Timothy P. Hughes

机构：Royal Adelaide Hospital, South Australian Health and Medical Research Institute, Australasian Leukaemia and Lymphoma Group, The University of Adelaide · ORCID：0000-0002-0910-3730

发表论文 807 篇 · 总被引 56404 次 · h-index 95

代表论文

• 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia (2025 · Leukemia · 被引 110)
• Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial (2025 · Blood · 被引 12)
• Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations (2025 · Blood · 被引 9)
• CARDINAL: A Phase 1 study of TERN-701, a novel investigational allosteric BCR::ABL1 inhibitor for patients with previously treated CML (2025 · Blood · 被引 5)
• Asciminib (ASC) demonstrates continued improvement in patient-reported outcomes (PROs) vs investigator-selected tyrosine kinase inhibitors (IS-TKIs) in newly diagnosed chronic myeloid leukemia (CML): ASC4FIRST week 96 analysis (2025 · Blood · 被引 1)
• Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities (2025 · Cancers · 被引 1)